Rafferty Asset Management
SGMO

Rafferty Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Rafferty Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-351,337
Closed -$358K – 1138
2024
Q4 		$358K Buy
+351,337
New +$642K ﹤0.01% 990
2023
Q2 		– Sell
-660,015
Closed -$1.16M – 1140
2023
Q1 		$1.16M Sell
660,015
-83,888
-11% -$239K 0.01% 768
2022
Q4 		$2.34M Buy
743,903
+304,949
+69% +$1.18M 0.02% 533
2022
Q3 		$2.15M Buy
438,954
+128,898
+42% +$662K 0.02% 492
2022
Q2 		$1.28M Sell
310,056
-181,645
-37% -$786K 0.01% 575
2022
Q1 		$2.86M Buy
491,701
+115,124
+31% +$685K 0.02% 518
2021
Q4 		$2.82M Buy
376,577
+177,395
+89% +$1.54M 0.01% 551
2021
Q3 		$1.79M Sell
199,182
-9,881
-5% -$97.7K 0.01% 671
2021
Q2 		$2.5M Sell
209,063
-79,667
-28% -$902K 0.02% 599
2021
Q1 		$3.62M Buy
288,730
+228,869
+382% +$3.08M 0.02% 378
2020
Q4 		$934K Sell
59,861
-128,740
-68% -$1.51M 0.01% 521
2020
Q3 		$1.78M Buy
188,601
+116,812
+163% +$1.26M 0.02% 451
2020
Q2 		$643K Buy
71,789
+56,456
+368% +$524K 0.01% 650
2020
Q1 		$98K Sell
15,333
-114,921
-88% -$853K ﹤0.01% 559
2019
Q4 		$1.09M Sell
130,254
-140,109
-52% -$1.29M 0.02% 535
2019
Q3 		$2.45M Buy
270,363
+7,986
+3% +$89.6K 0.04% 288
2019
Q2 		$2.83M Sell
262,377
-23,135
-8% -$246K 0.05% 265
2019
Q1 		$2.72M Buy
+285,512
New +$2.92M 0.04% 256

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Rafferty Asset Management's SGMO Position: Q1 2025 in Review

Rafferty Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2025, closing a stake of 351,337 shares — an estimated $358K sold.

Rafferty Asset Management first reported a position in SGMO in Q1 2019 and held it in 18 quarters. The position peaked at $3.62M in Q1 2021. 122 funds tracked by Wall St. Rank hold SGMO as of Q1 2025.

  • Rafferty Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 351,337 SANGAMO THERAPEUTICS INC shares in Q1 2025, an estimated $358K.
  • Rafferty Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2019 and held it in 18 quarters.
  • Rafferty Asset Management's SANGAMO THERAPEUTICS INC position peaked at $3.62M in Q1 2021.
  • 122 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2025.

Based on Rafferty Asset Management's 13F filing for Q1 2025, filed 14 May 2025.